Jersey’s medical cannabis industry turned a profit for the first time in 2025, posting revenues of £12m, almost £50m in
Ananda Developments [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”ANA.AQ” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] Aquis Stock Exchange-listed UK cannabis
ANANDA Developments has announced a number of heavyweight hires including a new COO, Head of Cultivation and Head of Plant
JAZZ Pharmaceuticals plc (Nasdaq: JAZZ) and its subsidiary, GW Pharmaceuticals (“GW”) – a world leader in discovering, developing and delivering
GW Pharmaceuticals has released further details of its cannabis development pipeline. With Epidiolex approved in the US last year it
CHANGES to immigration policy post-Brexit has resulted in a shortage of seasonal labour at UK-based medicinal cannabis cultivation sites, claims
LEADING UK cannabis company GW Pharmaceuticals has received the Queen’s Award for Enterprise 2021 in recognition of its ground-breaking work
THE last few weeks have witnessed a wild ride for global cannabis stocks reminiscent of some of the earlier bubbles
Good morning. Today is another post-Tom Brady Super Bowl Monday… Last week was a busy week one in cannabis last
IRISH firm Jazz Pharmaceuticals has agreed to purchase UK medical cannabis trailblazer GW Pharmaceuticals for $7.2bn. The deal will be
Well, this is the last Monday newsletter of 2020. For that, we are thankful. We will be winding down and
THE emerging cannabis industry is moving up the agenda for the pharmaceutical industry with two significant deals announced in the
ONE of the UK’s first cannabis investment funds is being backed by two of the industry’s global leaders as it
We won’t spam you
